Extracellular vesicles and pancreatitis: mechanisms, status and perspectives.
Comprehensive reviews and large population-based cohort studies have played an important role in the diagnosis and treatment of pancreatitis and its sequelae. The incidence and mortality of pancreatitis have been reduced significantly due to substantial advancements in the pathophysiological mechanisms and clinically effective treatments. The study of extracellular vesicles (EVs) has the potential to identify cell-to-cell communication in diseases such as pancreatitis. Exosomes are a subset of EVs with an average diameter of 50~150 nm. Their diverse and unique constituents include nucleic acids, proteins, and lipids, which can be transferred to trigger phenotypic changes of recipient cells. In recent years, many reports have indicated the role of EVs in pancreatitis, including acute pancreatitis, chronic pancreatitis and autoimmune pancreatitis, suggesting their potential influence on the development and progression of pancreatitis. Plasma exosomes of acute pancreatitis can effectively reach the alveolar cavity and activate alveolar macrophages to cause acute lung injury. Furthermore, upregulated exosomal miRNAs can be used as biomarkers for acute pancreatitis. Here, we summarized the current understanding of EVs in pancreatitis with an emphasis on their biological roles and their potential use as diagnostic biomarkers and therapeutic agents for this disease.
['Jia|Yu-Chen|YC|', 'Ding|Yi-Xuan|YX|', 'Mei|Wen-Tong|WT|', 'Wang|Yu-Ting|YT|', 'Zheng|Zhi|Z|', 'Qu|Yuan-Xu|YX|', 'Liang|Kuo|K|', 'Li|Jia|J|', 'Cao|Feng|F|', 'Li|Fei|F|']
extracellular vesicles pancreatitis exosomes biomarkers